Bank of America Corp DE boosted its position in BrightSpring Health Services, Inc. (NASDAQ: BTSG) by

BrightSpring Health Services (BTSG) has delivered 22% revenue CAGR over five years, with strong segm

BTSG Health Services raises its 2026 outlook as Pharmacy and Provider growth, margin gains and lower

Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improv

Micron, BrightSpring Health and Custom Truck One Source combine strong profitability with earnings g

BrightSpring Health is converting its large pharmacy revenue base into faster gross profit and EBITD

BJ's Restaurants, Patterson-UTI Energy and BrightSpring Health Services stand out after recent broke

Investors need to pay close attention to BTSG stock based on the movements in the options market lat

BrightSpring's broad-based growth and margin gains strengthen its outlook, but a premium valuation l

BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and ho

BrightSpring's 18.1% weekly slide clashes with strong growth and raised guidance as valuation, polic

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

BTSG's Q2 earnings and revenues beat estimates as pharmacy and provider growth drive margin gains an

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $

BrightSpring Health Services, Inc. (BTSG) Q2 2026 Earnings Call Transcript

While the top- and bottom-line numbers for BrightSpring Health Services, Inc. (BTSG) give a sense of

BrightSpring Health Services NASDAQ: BTSG reported second-quarter 2026 results that exceeded its bas

BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.45 per share, beati

BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the anal

BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion t

LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring

BrightSpring heads into Q2 earnings with pharmacy and provider momentum, rising estimates and margin

Dimensional Fund Advisors LP lowered its position in shares of BrightSpring Health Services, Inc. (N

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260714-1484349/1484349_gtls46.

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Consider

Raymond James analyst Parker Snure initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price

B of A Securities analyst Kevin Fischbeck maintains BrightSpring Health (NASDAQ:BTSG) with a Buy

Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the p

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises

Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises

BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. An

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and

Stephens & Co. analyst Raj Kumar maintains BrightSpring Health (NASDAQ:BTSG) with a Overweig

BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the p

BrightSpring shares rise after Q1 earnings beat, revenue growth and raised FY26 guidance; analysts c